NASDAQ:COWN
Delisted
Cowen Group Stock News
$38.99
+0 (+0%)
At Close: May 26, 2023
Berkeley Lights to Participate in Cowen 42nd Annual Health Care Conference
09:05pm, Monday, 28'th Feb 2022 GlobeNewswire
EMERYVILLE, Calif., Feb. 28, 2022 (GLOBE NEWSWIRE) -- Berkeley Lights, Inc. (Nasdaq: BLI), a leader in digital cell biology, today announced the Company will participate in the Cowen 42 nd Annual Health Care Conference, taking place virtually March 7-9, 2022.
Foghorn Therapeutics to Participate at the Cowen''s 42nd Annual Health Care Conference
09:05pm, Monday, 28'th Feb 2022 Benzinga
CAMBRIDGE, Mass., Feb. 28, 2022 (GLOBE NEWSWIRE) -- Foghorn ® Therapeutics Inc. (NASDAQ: FHTX ), a company pioneering the discovery and development of a new class of medicines targeting genetically determined dependencies within the chromatin regulatory system, today announced that Foghorn will participate on a panel at Cowen''s 42 nd Annual Health Care Conference which is being held virtually March 7 th through March 9 th , 2022. With an initial focus in oncology, Foghorn''s Gene Traffic Control ® Platform … Full story available on Benzinga.com
Best Value Stocks to Buy for February 28th
02:25pm, Monday, 28'th Feb 2022 Zacks Investment Research
ESEA, OMVJF, and CROX made it to the Zacks Rank #1 (Strong Buy) value stocks list on February 28, 2022
Cepton, Inc. Announces Upcoming Investor Conference Schedule
02:00pm, Monday, 28'th Feb 2022 Business Wire
Cepton (Nsdaq: CPTN) announces its participation in Cowen’s 2nd Annual Mobility Disruption Conference & Berenberg Industrial Technologies Conference
Jounce Therapeutics to Participate in Cowen & Co. 42nd Annual Health Care Conference
01:00pm, Monday, 28'th Feb 2022 GlobeNewswire
CAMBRIDGE, Mass., Feb. 28, 2022 (GLOBE NEWSWIRE) -- Jounce Therapeutics, Inc. (NASDAQ: JNCE), a clinical-stage company focused on the discovery and development of novel cancer immunotherapies and predictive biomarkers, today announced that Jounce management will participate in a novel immuno-oncology panel discussion at the Cowen & Co. 42 nd Annual Health Care Conference on Monday, March 7, 2022 at 10:30 a.m. ET.
Cowen Strengthens Equity Capital Markets Team With the Appointment of Brian Hagerty as Managing Director, Biotechnology
12:45pm, Monday, 28'th Feb 2022 GlobeNewswire Inc.
NEW YORK , Feb. 28, 2022 (GLOBE NEWSWIRE) -- Cowen Inc. (NASDAQ:COWN) (“Cowen” or the “Company”) today announced that Brian Hagerty has joined the company’s Equity Capital Markets team as
Best Value Stocks to Buy for February 28th
10:45am, Monday, 28'th Feb 2022
ESEA, OMVJF, and CROX made it to the Zacks Rank #1 (Strong Buy) value stocks list on February 28, 2022
Amarin to Participate in Cowen 42nd Annual Health Care Conference
01:00pm, Friday, 25'th Feb 2022 GlobeNewswire
DUBLIN, Ireland and BRIDGEWATER, N.J., Feb. 25, 2022 (GLOBE NEWSWIRE) -- Amarin Corporation plc (NASDAQ: AMRN) today announced that Karim Mikhail, president and chief executive officer of Amarin, is scheduled to participate virtually in a fireside chat at the Cowen 42nd Annual Health Care Conference on Monday, March 7 from 9:10 AM – 9:40 AM ET.
Cowen (COWN) Investor Presentation - Slideshow
06:53pm, Thursday, 24'th Feb 2022 Seeking AlphaCowen (COWN) Upgraded to Strong Buy: Here's Why
05:00pm, Thursday, 24'th Feb 2022 Zacks Investment Research
Cowen (COWN) has been upgraded to a Zacks Rank #1 (Strong Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
Best Value Stocks to Buy for February 24th
12:38pm, Thursday, 24'th Feb 2022 Zacks Investment Research
CCS, COWN, and VIST made it to the Zacks Rank #1 (Strong Buy) value stocks list on February 24, 2022
Best Value Stocks to Buy for February 24th
09:15am, Thursday, 24'th Feb 2022
CCS, COWN, and VIST made it to the Zacks Rank #1 (Strong Buy) value stocks list on February 24, 2022
Tyra Biosciences to Participate in Cowen 42nd Annual Healthcare Conference
09:05pm, Tuesday, 22'nd Feb 2022 PR Newswire
CARLSBAD, Calif., Feb. 22, 2022 /PRNewswire/ -- Tyra Biosciences, Inc. (Nasdaq: TYRA), a precision oncology company focused on developing purpose-built therapies to overcome tumor resistance and improve outcomes for patients with cancer, today announced that TYRA management will be
How This Payroll Company Is Fortifying Its Competitive Edge
12:00pm, Sunday, 20'th Feb 2022 The Motley Fool
This payroll services provider is more than meets the eye. Is now the time to buy?
Abbott infant formula recall could mean $325M revenue hit - Cowen (NYSE:ABT)
10:16pm, Friday, 18'th Feb 2022 Seeking Alpha
A recall of certain infant formula powders made by Abbott Laboratories (ABT) could cost the company $325M in annual revenue, according to Cowen.